Protagenic Therapeutics (PTIX) Competitors $0.62 -0.07 (-10.17%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsShort InterestTrends PTIX vs. TSBX, SNSE, INDP, HCWB, TRIB, SNTI, PHXM, EGRX, KPRX, and JAGXShould you be buying Protagenic Therapeutics stock or one of its competitors? The main competitors of Protagenic Therapeutics include Turnstone Biologics (TSBX), Sensei Biotherapeutics (SNSE), Indaptus Therapeutics (INDP), HCW Biologics (HCWB), Trinity Biotech (TRIB), Senti Biosciences (SNTI), PHAXIAM Therapeutics (PHXM), Eagle Pharmaceuticals (EGRX), Kiora Pharmaceuticals (KPRX), and Jaguar Health (JAGX). These companies are all part of the "pharmaceutical products" industry. Protagenic Therapeutics vs. Turnstone Biologics Sensei Biotherapeutics Indaptus Therapeutics HCW Biologics Trinity Biotech Senti Biosciences PHAXIAM Therapeutics Eagle Pharmaceuticals Kiora Pharmaceuticals Jaguar Health Protagenic Therapeutics (NASDAQ:PTIX) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment. Is PTIX or TSBX more profitable? Turnstone Biologics' return on equity of -105.99% beat Protagenic Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Protagenic TherapeuticsN/A -238.38% -185.60% Turnstone Biologics N/A -105.99%-87.27% Which has stronger valuation and earnings, PTIX or TSBX? Protagenic Therapeutics has higher earnings, but lower revenue than Turnstone Biologics. Protagenic Therapeutics is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProtagenic TherapeuticsN/AN/A-$5M-$1.45-0.43Turnstone Biologics$19.31M0.59-$55.20M-$3.24-0.15 Do analysts rate PTIX or TSBX? Turnstone Biologics has a consensus target price of $2.13, indicating a potential upside of 333.41%. Given Turnstone Biologics' stronger consensus rating and higher probable upside, analysts clearly believe Turnstone Biologics is more favorable than Protagenic Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Protagenic Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer PTIX or TSBX? Turnstone Biologics received 4 more outperform votes than Protagenic Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformProtagenic TherapeuticsN/AN/ATurnstone BiologicsOutperform Votes450.00% Underperform Votes450.00% Do insiders & institutionals believe in PTIX or TSBX? 8.0% of Protagenic Therapeutics shares are owned by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are owned by institutional investors. 37.0% of Protagenic Therapeutics shares are owned by insiders. Comparatively, 32.1% of Turnstone Biologics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to PTIX or TSBX? In the previous week, Turnstone Biologics had 6 more articles in the media than Protagenic Therapeutics. MarketBeat recorded 8 mentions for Turnstone Biologics and 2 mentions for Protagenic Therapeutics. Protagenic Therapeutics' average media sentiment score of 1.21 beat Turnstone Biologics' score of 0.36 indicating that Protagenic Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Protagenic Therapeutics Positive Turnstone Biologics Neutral Which has more risk & volatility, PTIX or TSBX? Protagenic Therapeutics has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500. SummaryTurnstone Biologics beats Protagenic Therapeutics on 11 of the 15 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTIX vs. The Competition Export to ExcelMetricProtagenic TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.76M$6.39B$5.06B$8.67BDividend YieldN/A8.04%5.06%4.06%P/E Ratio-0.4310.0598.5017.08Price / SalesN/A266.581,205.7371.31Price / CashN/A53.4940.6936.36Price / Book0.749.306.325.87Net Income-$5M$154.14M$119.47M$225.66M7 Day Performance2.99%-9.49%-5.11%-1.34%1 Month Performance10.57%-7.23%-3.21%1.00%1 Year Performance-23.70%30.70%32.41%25.27% Protagenic Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTIXProtagenic Therapeutics1.7536 of 5 stars$0.62-10.2%N/A-27.7%$2.76MN/A-0.431Short Interest ↓Positive NewsGap DownTSBXTurnstone Biologics3.4913 of 5 stars$0.52-2.3%N/A-84.0%$12.07M$19.31M-0.1682Earnings ReportAnalyst DowngradeNews CoverageSNSESensei Biotherapeutics4.729 of 5 stars$0.47-11.8%N/A-25.0%$11.80MN/A-0.4040Upcoming EarningsNews CoverageGap DownHigh Trading VolumeINDPIndaptus Therapeutics2.7835 of 5 stars$1.16-1.7%N/A-49.5%$11.78MN/A-0.686Earnings ReportAnalyst ForecastShort Interest ↑HCWBHCW Biologics1.755 of 5 stars$0.31flatN/A-68.0%$11.72M$2.84M-0.3040Short Interest ↓News CoverageGap DownHigh Trading VolumeTRIBTrinity Biotech1.899 of 5 stars$1.53-1.3%N/A-36.1%$11.66M$56.83M-0.57480Short Interest ↓News CoverageGap DownSNTISenti Biosciences0.8322 of 5 stars$2.33+3.6%N/A-42.2%$10.67M$2.56M-0.184News CoveragePositive NewsGap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049EGRXEagle Pharmaceuticals1.1313 of 5 stars$0.80+6.5%N/A-92.6%$10.38M$316.61M0.00134Analyst ForecastNews CoverageGap UpKPRXKiora Pharmaceuticals3.3501 of 5 stars$3.39-1.5%N/A-36.7%$10.17MN/A0.0010Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoveragePositive NewsGap UpJAGXJaguar Health0.6389 of 5 stars$1.07+8.3%N/A-95.8%$9.89M$10.19M0.0050Short Interest ↑News Coverage Related Companies and Tools Related Companies Turnstone Biologics Alternatives Sensei Biotherapeutics Alternatives Indaptus Therapeutics Alternatives HCW Biologics Alternatives Trinity Biotech Alternatives Senti Biosciences Alternatives PHAXIAM Therapeutics Alternatives Eagle Pharmaceuticals Alternatives Kiora Pharmaceuticals Alternatives Jaguar Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PTIX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagenic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTIX Stock Alerts